Agilon Health, Inc. cash flow to debt ratio of -287.28% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Agilon Health, Inc.'s free cash flow has decreased 67.55% from $-71.03M last year to $-119.00M, signaling decreasing performance

Agilon Health, Inc.'s debt to equity ratio is 0.15, which means that the company's assets are healthy financed, signaling financial stability.

Agilon Health, Inc.'s debt has increased relative to shareholder equity from 0.09 last year to 0.15 today, signaling weakened financials

Agilon Health, Inc. has a net cash position, so leverage is healthy.

Agilon Health, Inc.'s interest coverage ratio is -79.13, which means that the company struggles to meet interest obligations, signaling financial risk.

Agilon Health, Inc.'s profit margin has increased (-1.16%) in the last year from -4.29% to -4.24%, signaling increasing performance

Agilon Health, Inc.'s short-term assets of $1.10B exceed its short-term liabilities of $1.08B

Agilon Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Agilon Health, Inc.'s return on equity of -119.35%, is lower than 15.00%, indicating bad performance

Agilon Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Agilon Health, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Agilon Health, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Agilon Health, Inc. has negative free cash flow, indicating cash burn

Agilon Health, Inc.'s yearly earnings has decreased 55.81% since last year from $-260.15M to $-405.35M, signaling decreasing performance

Agilon Health, Inc.'s yearly revenue has decreased 2.11% since last year from $6.06B to $5.93B, signaling decreasing performance

ROIC -90.22% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Agilon Health, Inc.'s 3-year revenue CAGR of 35.43% is positive, indicating growing revenue over the past 3 years

Agilon Health, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Agilon Health, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Agilon Health, Inc. has insufficient data to evaluate this check.

Agilon Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Agilon Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Agilon Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Agilon Health, Inc. has insufficient data to evaluate this check.

Agilon Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Agilon Health, Inc. has a price-to-book ratio of 7.11x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Agilon Health, Inc. has a price-to-sales ratio of 0.27x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue